Article Details

Biotech Announces Deal with Bayer on Non-Hormonal Contraception

Retrieved on: 2020-01-15 01:26:15

Tags for this article:

Click the tags to see associated articles and topics

Biotech Announces Deal with Bayer on Non-Hormonal Contraception. View article details on hiswai:

Excerpt

<div>Dawson James has a Buy rating and a $4 per share price target on Daré Bioscience, whose <b>stock</b> is currently trading at around $1.39 per share.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up